Otrinazil (Xylometazoline Hydrochloride, Dexpanthenol)

Xylometazoline Hydrochloride, the active ingredient in Otrinazil, is a nasal decongestant presented as a nasal spray for intranasal use. It reduces nasal swelling and improves airflow in patients with congestion caused by colds, sinusitis or allergies.

GNH USA supplies Otrinazil as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Otrinazil, a nasal decongestant, acts on the upper‑respiratory tract to relieve congestion associated with several common conditions. - Nasal congestion due to common cold: alleviates swelling of nasal mucosa and restores normal breathing. - Sinusitis‑related nasal blockage: reduces mucosal edema, facilitating sinus drainage. - Allergic rhinitis: diminishes nasal congestion caused by allergic inflammation.

Adverse reactions may occur with intranasal use of Otrinazil. Most are mild and reversible.

Common Side Effects: - Nasal irritation: mild burning or stinging sensation. - Sneezing: transient increase in sneezing episodes. - Dryness of nasal mucosa: feeling of dryness or crusting. - Headache: mild, short‑lasting headache. - Taste disturbance: temporary alteration of taste perception.

Serious or Rare Side Effects: - Rebound congestion: worsening nasal blockage after prolonged use. - Hypertension: elevated blood pressure in susceptible individuals. - Cardiac arrhythmia: irregular heart rhythm in patients with underlying heart disease. - Severe allergic reaction: rash, swelling, or difficulty breathing. - Nasal ulceration: rare ulcer formation in the nasal passages.

Before using Otrinazil, consider the following safety measures. - Duration of use: limit to no more than 3‑5 consecutive days to avoid rebound congestion. - Cardiovascular disease: avoid if you have uncontrolled hypertension or heart disease. - Pregnancy and lactation: consult a healthcare professional before use. - Children under 6 years: not recommended unless prescribed by a clinician. - Drug interactions: inform your doctor of any concurrent nasal or systemic decongestants. - Store at ambient temperature: keep below 25 °C, protect from moisture and direct sunlight.

Otrinazil may interact with other medications that affect vascular tone or blood pressure.

Major Interactions (Avoid):\n- Monoamine oxidase inhibitors (MAOIs): risk of excessive vasoconstriction. - Systemic decongestants (e.g., pseudoephedrine): potential for severe hypertension.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may blunt the cardiovascular response. - Antihypertensive agents: monitor blood pressure for additive effects. - Anticholinergic drugs: possible increase in nasal dryness.